Kato T, Shindo M
Gan To Kagaku Ryoho. 1982 Mar;9(3):357-64.
Though a variety of treatments have been employed as an adjuvant for renal cell carcinoma, none of them has proved to be significantly effective, suggesting the difficulty in the treatment of this disease. The transcatheter arterial chemoembolization utilizing mitomycin C microcapsules developed by us was applied to renal cell carcinoma with an attempt at enhancing the chemotherapy and embolization. The early results indicate that this mode of treatment facilitates radical nephrectomy due to its marked antineoplastic effects and provides a favourable prognosis in locally advanced renal cancer. The experimental and clinical profiles of intra-arterial microcapsules were presented.
尽管已经采用了多种治疗方法作为肾细胞癌的辅助治疗，但没有一种被证明具有显著疗效，这表明该疾病治疗存在困难。我们研发的利用丝裂霉素C微胶囊的经导管动脉化疗栓塞术应用于肾细胞癌，旨在增强化疗和栓塞效果。早期结果表明，这种治疗方式因其显著的抗肿瘤作用有利于根治性肾切除术，并为局部晚期肾癌提供良好的预后。本文介绍了动脉内微胶囊的实验和临床情况。
